Rare clinical experiences for surgical treatment of melanoma with osseous metastases in Taiwan
暂无分享,去创建一个
Rong-Sen Yang | Rong-Sen Yang | Chrong-Reen Wang | Chrong-Reen Wang | Kuo-Yuan Huang | Kuo-Yuan Huang
[1] Chun-Ying Wu,et al. Clinicopathologic analysis of malignant melanoma in Taiwan. , 1999, Journal of the American Academy of Dermatology.
[2] C. Harmer,et al. Spontaneous regression of multiple bone metastases in malignant melanoma. , 1989, British Journal of Radiology.
[3] D. Morton,et al. Prognostic factors in 1,521 melanoma patients with distant metastases. , 1995, Journal of the American College of Surgeons.
[4] P. Wiffen,et al. Bisphosphonates for the relief of pain secondary to bone metastases. , 2002, The Cochrane database of systematic reviews.
[5] A. Jemal,et al. Cancer Statistics, 2007 , 2007, CA: a cancer journal for clinicians.
[6] C. Riebeling,et al. The bisphosphonate pamidronate induces apoptosis in human melanoma cells in vitro , 2002, British Journal of Cancer.
[7] D. Reintgen,et al. Recurrent malignant melanoma: the identification of prognostic factors to predict survival. , 1992, Annals of plastic surgery.
[8] G. Hortobagyi,et al. Pamidronate prevents skeletal complications and is effective palliative treatment in women with breast carcinoma and osteolytic bone metastases , 2000, Cancer.
[9] J. Naeyaert,et al. Understanding the trends in melanoma incidence and mortality: where do we stand? , 2000, European journal of dermatology : EJD.
[10] B. Lamm,et al. Metastatic malignant melanoma to the foot and ankle: a review of the literature and case report. , 2000, The Journal of foot and ankle surgery : official publication of the American College of Foot and Ankle Surgeons.
[11] N. Dubrawsky. Cancer statistics , 1989, CA: a cancer journal for clinicians.
[12] L. Wold,et al. Malignant melanoma metastatic to bone. , 1992, Orthopedics.
[13] W. Hohenberger,et al. Palliative radiotherapy for recurrent and metastatic malignant melanoma: prognostic factors for tumor response and long-term outcome: a 20-year experience. , 1999, International journal of radiation oncology, biology, physics.
[14] M. Atkins,et al. The treatment of metastatic melanoma with chemotherapy and biologics. , 1997, Current opinion in oncology.
[15] H. Schwartz,et al. Heterogeneous Survival Rates for Isolated Skeletal Metastases From Melanoma , 1996, Clinical orthopaedics and related research.
[16] M. Kersten,et al. Temozolomide followed by combined immunotherapy with GM-CSF, low-dose IL2 and IFNα in patients with metastatic melanoma , 2003, British Journal of Cancer.
[17] D. Miller,et al. Update on the incidence and mortality from melanoma in the United States. , 1999, Journal of the American Academy of Dermatology.
[18] D. Reintgen,et al. Metastatic melanoma: chemotherapy to biochemotherapy. , 2002, Cancer control : journal of the Moffitt Cancer Center.
[19] R. Yokoyama,et al. Primary malignant melanoma (clear cell sarcoma) of bone: Report of a case arising in the ulna , 1996, Cancer.
[20] H. Jaeger,et al. Patellar metastasis from a malignant melanoma , 2004, International Orthopaedics.
[21] J. Berenson. Recommendations for zoledronic acid treatment of patients with bone metastases. , 2005, The oncologist.
[22] R. Essner,et al. The role of surgery in treatment of stage IV melanoma , 2006, Journal of surgical oncology.
[23] S. Aoyagi,et al. Pedunculated Melanoma with Pulmonary and Bony Metastases , 2000, Journal of dermatology (Print).
[24] Intra-articular metastatic melanoma of the right knee. , 1999, Arthroscopy : the journal of arthroscopic & related surgery : official publication of the Arthroscopy Association of North America and the International Arthroscopy Association.